Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Regulatory News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.40
Ask: 1.70
Change: -0.05 (-3.13%)
Spread: 0.30 (21.429%)
Open: 1.60
High: 1.60
Low: 1.55
Prev. Close: 1.60
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of EGM

27 Apr 2012 11:47

RNS Number : 2426C
Flying Brands Limited
27 April 2012
 



27 April 2012

 

FLYING BRANDS LIMITED

 

RESULT OF EXTRAORDINARY GENERAL MEETING ("EGM")

 

 

Flying Brands Limited (the "Company") is pleased to announce that the resolutions put to shareholders at the Company's EGM held earlier today relating to the proposed disposal of the Gifts Division (the "Gifts Disposal") and the proposed disposal of the Garden Bird Supplies, Garden Centre Online and Listen2 businesses (the "BG&L Disposal") were duly passed on a show of hands.

 

Following shareholder approval, the Company expects both the Gifts Disposal and the BG&L Disposal to complete on 30 April 2012.

 

The following levels of proxy appointments were received by the Company prior to the EGM:

Resolutions

For

Against

Chairman's discretion (Note i)

Votes withheld

Number of shares

% of total

Number of shares

% of total

Number of shares

% of total

To approve the disposal of the Gifts division

15,988,086

 

99.83

5,516

0.03

22,338

0.14

233

To approve the disposal of the BG&L Businesses and the Domain Name Disposal

15,822,990

98.8

21,016

0.13

171,937

1.07

233

 

Notes:

(i) Proxy appointments which gave discretion to the Chairman have been cast in favour of each resolution.

 

(ii) Issued share capital at 27 April 2012: 28,073,735 ordinary shares. Proxy appointments were received from shareholders of 16,015,940 ordinary shares amounting to 57.05% of the issued share capital.

 

(iii) A "Vote Withheld" is not counted towards the votes cast "For" or "Against" the resolutions.

 

A copy of the resolutions passed at the EGM is available for inspection on the National Storage Mechanism at www.hemscott.com/nsm.do.

 

For further information, please contact:

 

Flying Brands Limited 01245 228 300

Stephen Cook, Chief Executive

Stuart Dootson, Group Finance Director

 

Singer Capital Markets Limited 020 3205 7500

Claes Spang

Nick Donovan

 

Smithfield Consultants 020 7360 4900

John Kiely

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
REGIRMMTMBJTBTT
Date   Source Headline
29th Apr 20243:26 pmRNSPublication of Annual Report
5th Mar 20247:00 amRNSGrant of Options
1st Mar 20248:22 amRNSHolding(s) in Company
1st Mar 20248:20 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSResult of Broker Option and Total Voting Rights
22nd Feb 20247:00 amRNSPlacing and Broker Option
9th Feb 202412:49 pmRNSFDA Application Update
2nd Feb 20248:39 amRNSIB awarded a $100,000 grant
22nd Jan 202410:05 amRNSHolding(s) in Company
15th Jan 20247:01 amRNSDirector Dealings and Conversion of CLNs
15th Jan 20247:00 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSIB Launching an Expanded Access Program for GaM
19th Dec 20232:29 pmRNSImaging Biometrics granted FDA “Fast-Track”
5th Dec 202310:58 amRNSIQ-AI Announces Positive Interim Phase 1 Results
20th Nov 20231:42 pmRNSHolding(s) in Company
9th Nov 202311:38 amRNSDirector Dealing and Conversion of CLNs
8th Nov 202310:59 amRNSApplication for Pediatric Rare Disease Designation
6th Nov 20231:02 pmRNSHolding(s) in Company
18th Oct 20232:29 pmRNSUpdate Regarding Imaging Biometrics LLC
13th Oct 20238:55 amRNSIB Letter to Shareholders
9th Oct 20237:00 amRNSOrphan Drug Status to GaM and Total Voting Rights
3rd Oct 202311:30 amRNSHolding(s) in Company
19th Sep 20232:32 pmRNSIQ-AI shares cease trading on the OTCQB
8th Sep 20237:00 amRNSReduced Gadolinium Approach Validated'
18th Aug 202312:06 pmRNSUpdate on Collaboration Agreement with Mayo Clinic
18th Aug 202311:20 amRNSIB & GE HealthCare Enter into Commercial Agreement
17th Aug 20237:00 amRNSHalf-year Report
19th Jul 20237:00 amRNSImaging Biometrics Installs IB Nimble™ For MCW
13th Jul 20237:00 amRNSOrphan Drug Designation for GaM in Pediatric GBM
27th Jun 20237:00 amRNSStudies Show GaM Inhibits Pediatric Tumor Growth
23rd May 202311:02 amRNSResult of AGM
23rd May 20237:00 amRNSAGM Statement
3rd May 20234:14 pmRNSNotice of AGM
26th Apr 20237:00 amRNSFinal Results
28th Feb 20233:52 pmRNSOrphan Drug Designation Status
13th Jan 20232:05 pmRNSSecond Price Monitoring Extn
13th Jan 20232:00 pmRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSLetter to Shareholders
2nd Dec 202211:11 amRNSHolding in Company
25th Oct 202211:00 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSLetter to Shareholders
26th Sep 20227:00 amRNSIssue of Warrants to Employees
16th Aug 20224:40 pmRNSSecond Price Monitoring Extn
16th Aug 20224:35 pmRNSPrice Monitoring Extension
16th Aug 20229:28 amRNSHalf-year Report
3rd Aug 20221:01 pmRNSTR1 - Notification of Major Holdings
11th Jul 20227:00 amRNSImaging Biometrics Announces Channel Partnership
31st May 202211:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.